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Dear Editor,
Before AIDS, cryptococcal meningitis, a dis-
ease caused by the basidiomycete fungus 
Cryptococcus neoformans, occurred at an 
incidence rate of one case per one million per-
son-years.1 After AIDS, transplants and the use 
of immunosuppressive therapies, the incidence 
rate increased tenfold.1,2 
We report a case of a 46-year-old male 
with a history of headache, confusion, nausea 
and vomiting for one month. The patient also 
had type 2 diabetes mellitus, in use of metform-
in, with good control, and liver cirrhosis due to 
hepatitis C. Treatment with pegylated interferon 
and ribavirin had begun two months before clin-
ical presentation. After the second dose of inter-
feron, pancytopenia was observed (hemoglobin: 
10.9 g/dL, leukocytes: 3,660 cells/µL, platelets: 
36,000/µL), decompensated cirrhosis and dia-
betes mellitus, characterized by moderate as-
cites and grade 3 hepatic encephalopathy, which 
overlapped the clinical symptoms described 
above, despite treatment with therapeutic doses 
of furosemide, spironolactone, lactulose, NPH 
and regular human insulin. Patient was listed for 
liver transplantation. Model of End-Stage Liver 
Disease (MELD) score equals 14 points.
At presentation, cerebrospinal fluid (CSF) 
showed 21 cells/mL, total protein = 96 mg/dL, 
glucose = 34 mg/dL (serum glucose: 
290 mg/dL), positive India ink staining and 
cryptococcal antingen titer greater than 
1/1,024. Culture for C. neoformans was posi-
tive in the CSF, but negative in blood, bone 
marrow and ascites. Central nervous sys-
tem computed tomography and magnetic 
resonance imaging has showed only mild su-
pratentorial hydrocephalous. Patient evolved 
with intracranial hypertension (the first open-
ing pressure: 36 cmH2O), without improve-
ment by lumbar puncture. Ventriculoperito-
neal shunt was performed after two units of 
apheresis platelets transfusion. 
The patient was treated with amphotericin 
B lipid complex 5 mg/kg/day for 30 days and 
5-fluorocytosine 100 mg/kg/day for 14 days 
until three negative cultures for C. neofor-
mans were obtained. During treatment, he 
presented elevated creatinine (2.0 mg/dL), 
but without requiring dialysis. There was no 
worsening of pancytopenia during treatment. 
Strict monitoring of renal and liver function 
and bone marrow was performed. 
Before starting fluconazole 800 mg/day, 
the patient has presented bloodstream infec-
tion associated with central venous catheter 
by Enterococcus faecalis, and despite appropri-
ate treatment with vancomycin for 10 days, the 
patient progressed with septic shock syndrome 
and multiple organ dysfunction syn- 
drome (MODS) and died 40 days after admission. 
Cryptococcosis affects the central nerv-
ous system in 51.3% of HIV-negative pa-
tients, after the introduction of azole agents 
in the market, and in 39% of patients with 
cirrhosis, as suggested by the two largest 
studies in the literature.3,4 The peritoneum 
is the site most associated with cryptococcal 
infection in cirrhotic patients (45%).4 
In 306 HIV-negative patients, the un-
derlying causes were steroids (28%), or-
gan transplant (18%), chronic shortage 
of organs (liver, respiratory and renal) 
(18%), neoplasm (18%), rheumatic diseases 
(13%), and unknown risk factor (22%).3 
Malnutrition, in addition to compromised 
phagocytosis, immunoglobulins and cel-
lular immunity result in increased risk of 
cryptococcosis in cirrhotic patients.4 The 
case fatality rate associated with cryptococ-
cosis in cirrhotic patients is 83%, 92% of 
which attributed to cryptococcosis. In 53% 
of cases, death occurs in the second week of 
diagnosis. Culture positivity is 67% and 
India ink in around 50% in cirrhotic pa-
tients and HIV-negative, respectively.1,2 
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This case was a rare example of cryptococcosis without 
dissemination in an HIV-negative patient. Combined treat-
ment with fluorocytosine and amphotericin B lipid complex 
resulted in CSF sterilization, but a bacterial bloodstream 
infection, in spite of appropriate treatment, was the cause 
of death, which might be attributed to immunosuppression 
caused by underlying disease.
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